PCIDB

KNApSAcK Metabolite C00015693

Metabolite

KNApSAcK Entry

id C00015693
Name lpha-Viniferin / (+)-alpha-Viniferin
CAS RN 62218-13-7
Standard InChI InChI=1S/C42H30O9/c43-22-7-1-19(2-8-22)40-37-28-13-25(46)17-32-35(28)39(42(50-32)21-5-11-24(45)12-6-21)30-15-27(48)18-33-36(30)38(29-14-26(47)16-31(49-40)34(29)37)41(51-33)20-3-9-23(44)10-4-20/h1-18,37-48H/t37-,38-,39+,40+,41+,42-/m0/s1
Standard InChI (Main Layer) InChI=1S/C42H30O9/c43-22-7-1-19(2-8-22)40-37-28-13-25(46)17-32-35(28)39(42(50-32)21-5-11-24(45)12-6-21)30-15-27(48)18-33-36(30)38(29-14-26(47)16-31(49-40)34(29)37)41(51-33)20-3-9-23(44)10-4-20/h1-18,37-48H

Cluster

Phytochemical cluster No. 30
KCF-S cluster No. 163

Link

ChEMBL

By standard InChI
By standard InChI Main Layer CHEMBL443463 CHEMBL1997745

KEGG

By LinkDB

CTD

By CAS RN C064176

Human Protein / Gene in interaction

1 ChEMBL Protein in interactions

accession description class description compound assay ID (# of activities) # of diseases
(OMIM / KEGG)
P35354 Prostaglandin G/H synthase 2 Oxidoreductase CHEMBL443463 CHEMBL2346087 (1)
0 / 3

CTD interaction (2)

compound gene gene name gene description interaction interaction type form reference
pmid
C064176 4363 ABCC1
ABC29
ABCC
GS-X
MRP
MRP1
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 alpha-viniferin inhibits the reaction [ABCC1 protein results in increased transport of 2',7'-bis-(carboxypropyl)-5(6)-carboxyfluorescein] decreases reaction
/ increases transport
protein 16827148
C064176 4363 ABCC1
ABC29
ABCC
GS-X
MRP
MRP1
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 alpha-viniferin results in decreased activity of ABCC1 protein decreases activity
protein 16827148

Related Disease

Diseases related to proteins in ChEMBL interactions

KEGG DISEASE (3)

KEGG disease name UniProt
H00017 Esophageal cancer P35354 (related)
H00025 Penile cancer P35354 (related)
H00046 Cholangiocarcinoma P35354 (related)

Diseases related to CTD interactions

2 disease from interactions of metabolites

MeSH disease OMIM compound disease name evidence type reference
pmid
D004487 C064176 Edema therapeutic
14531020
D007249 C064176 Inflammation therapeutic
14531020